Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Visipat 0.1% Eye Drop

Prescription Icon
Prescription Required

Marketer

Asta Visioncare Pvt Ltd

Salt Composition

Olopatadine (0.1% w/v)

Overview Visipat 0.1% Eye Drop

Allergic conjunctivitis, characterized by eye irritation, redness, swelling, and itching from allergens like pollen, dust, or pet dander, responds to Visipat 0.1% eye drops, an antihistamine. This medication should be administered as directed by your physician, maintaining consistent dosing intervals to complete the prescribed treatment course. While temporary burning, stinging, or irritation may occur, consistent use is crucial even with symptom improvement.

Primary Ingredients of Visipat 0.1% Eye Drop

No text was provided to rewrite.

Uses of Visipat 0.1% Eye Drop

Managing Allergic Reactions

Major Benefits of Visipat 0.1% Eye Drop:

Apply this medication externally only. Administer as directed by your physician, adhering to the prescribed dosage and timeframe. Consult the product label for application instructions prior to use. Position the dropper near the eye, avoiding contact. Carefully dispense the medication into the lower conjunctival sac. Remove any excess solution.

Common Side effects of Visipat 0.1% Eye Drop:

  • Eye pain
  • Eye irritation
  • Abnormal eye sensation
  • Eye discomfort
  • Sleepiness
  • Weakness
  • Dryness in mouth

How to use Visipat 0.1% Eye Drop:

Apply this medication externally only. Administer the prescribed dosage for the specified duration as directed by your physician. Consult the product label for application instructions. Position the dropper near the eye, avoiding contact. Carefully dispense the medication into the lower conjunctival sac. Remove any excess solution.

How Visipat 0.1% Eye Drop works:

Allergy relief is provided by Visipat 0.1% ophthalmic solution, an antihistamine. Its mechanism of action involves inhibiting histamine, a chemical mediator causing ocular redness, itching, and tearing.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Visipat 0.1% Eye Drops during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and the use of Visipat 0.1% Eye Drops may pose a risk. Available evidence in humans indicates potential transfer to breast milk, with a possible risk of infant harm.

DrivingDrivingUNSAFE

Following application of Visipat 0.1% Eye Drops, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.

KidneyKidneyNone

No known drug interactions.

LiverLiverNone

No known drug interactions.

What if you forget to take Visipat 0.1% Eye Drop :

Should you forget a dose of Visipat 0.1% Eye Drops, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Visipat 0.1% Eye Drop

LabelValue
Type of Compound Dibenzoxepine-based compound
Potential for Dependence None.
Type of Medication Eye medication.

FAQs on Visipat 0.1% Eye Drop

Visipat 0.1% ophthalmic solution does not contain steroids. This medication manages allergic conditions, primarily allergic conjunctivitis. Always seek medical advice before using this product.
Using Visipat 0.1% eye drops as directed by your physician ensures optimal effectiveness. Continue treatment for the prescribed period, even with symptom improvement. Premature discontinuation of Visipat 0.1% eye drops may lead to symptom recurrence or exacerbation.
Visipat 0.1% Eye Drops typically do not irritate the eyes; the medication is formulated to lessen existing inflammation and irritation. Nevertheless, some individuals might encounter eye irritation, unusual sensations, or general eye discomfort.
Visipat 0.1% ophthalmic solution may be administered to children over three years old using the adult dosage. The safety profile of Visipat 0.1% ophthalmic solution in children under three years old is undetermined; consequently, its use in this age group is not recommended.
Visipat 0.1% Eye Drops typically do not induce drowsiness. Nevertheless, somnolence may occur in certain instances. Concomitant oral use of other antihistamines may increase the likelihood of sleepiness. Refrain from operating vehicles or heavy machinery if drowsiness is experienced. Consult your physician if any discomfort arises.
Administer one drop of Visipat 0.1% Eye Drops into the affected eye(s) twice daily. Treatment length with Visipat 0.1% Eye Drops varies depending on the condition, its severity, and individual patient response. Treatment may extend to four months if deemed appropriate, but the precise duration should be determined by your physician.
Using Visipat 0.1% Eye Drops as directed by your physician ensures optimal effectiveness. Continue treatment for the prescribed period, even with symptom improvement. Premature discontinuation of Visipat 0.1% Eye Drops may lead to symptom recurrence or exacerbation.
Visipat 0.1% Eye Drops typically do not irritate the eyes; their purpose is to alleviate existing inflammation and discomfort. Nevertheless, some individuals might encounter eye irritation, unusual sensations, or general eye discomfort.
Visipat 0.1% ophthalmic solution may be administered to children older than 3 years at the adult dosage. The safety profile of Visipat 0.1% ophthalmic solution in children younger than 3 years remains undetermined. Consequently, its use in this younger age group is contraindicated.
Visipat 0.1% Eye Drops typically do not induce drowsiness. Nevertheless, somnolence is a potential side effect. Concurrent oral use of other antihistamines may increase the likelihood of sleepiness. Refrain from operating vehicles or heavy machinery if drowsiness occurs. Consult your physician if you experience any discomfort.
Administer one drop of Visipat 0.1% Eye Drops into the affected eye(s) twice daily. The treatment period for Visipat 0.1% Eye Drops varies depending on the illness, its intensity, and the patient's response. Treatment may extend up to four months if deemed appropriate, but the precise duration should be determined by your physician.
Allergic rhinitis, an allergic nasal inflammation, may be treated with Visipat 0.1% Eye Drops. This medication manages symptoms such as sneezing and rhinorrhea. It's also indicated for certain skin conditions, including urticaria and pruritus.
Administer this medication solely as directed by your physician. The typical regimen involves one tablet twice daily, once in the morning and once after the evening meal. Your doctor will determine the precise dosage and treatment length.
Long-term eye itching, medically known as chronic urticaria, may be treated with Visipat 0.1% Eye Drops. However, a diagnosis from a healthcare professional is necessary before commencing this treatment. They will determine the correct dosage and treatment length.
Visipat 0.1% Eye Drops may offer relief from hay fever (pollinosis) symptoms caused by pollen. Consult your physician prior to using this medication for hay fever. For pollinosis, treatment typically continues throughout the pollen season to help prevent symptom recurrence.
Visipat 0.1% Eye Drop
62
MRP 76
18% off